Evaluation of the protective efficacy of a spatial repellent to reduce malaria incidence in children in western Kenya compared to placebo: study protocol for a cluster-randomized double-blinded control trial (the AEGIS program)

Eric O Ochomo, John E Gimnig, Achuyt Bhattarai, Aaron M Samuels, Simon Kariuki, George Okello, Bernard Abong'o, Eunice A Ouma, Jackline Kosgei, Stephen Munga, Kiambo Njagi, Wycliffe Odongo, Fang Liu, John P Grieco, Nicole L Achee, Eric O Ochomo, John E Gimnig, Achuyt Bhattarai, Aaron M Samuels, Simon Kariuki, George Okello, Bernard Abong'o, Eunice A Ouma, Jackline Kosgei, Stephen Munga, Kiambo Njagi, Wycliffe Odongo, Fang Liu, John P Grieco, Nicole L Achee

Abstract

Background: Spatial repellents are widely used for prevention of mosquito bites and evidence is building on their public health value, but their efficacy against malaria incidence has never been evaluated in Africa. To address this knowledge gap, a trial to evaluate the efficacy of Mosquito Shield™, a spatial repellent incorporating transfluthrin, was developed for implementation in Busia County, western Kenya where long-lasting insecticidal net coverage is high and baseline malaria transmission is moderate to high year-round.

Methods: This trial is designed as a cluster-randomized, placebo-controlled, double-blinded clinical trial. Sixty clusters will be randomly assigned in a 1:1 ratio to receive spatial repellent or placebo. A total of 6120 children aged ≥6 months to 10 years of age will be randomly selected from the study clusters, enrolled into an active cohort (baseline, cohort 1, and cohort 2), and sampled monthly to determine time to first infection by smear microscopy. Each cohort following the implementation of the intervention will be split into two groups, one to estimate direct effect of the spatial repellent and the other to estimate degree of diversion of mosquitoes and malaria transmission to unprotected persons. Malaria incidence in each cohort will be estimated and compared (primary indicator) to determine benefit of using a spatial repellent in a high, year-round malaria transmission setting. Mosquitoes will be collected monthly using CDC light traps to determine if there are entomological correlates of spatial repellent efficacy that may be useful for the evaluation of new spatial repellents. Quarterly human landing catches will assess behavioral effects of the intervention.

Discussion: Findings will serve as the first cluster-randomized controlled trial powered to detect spatial repellent efficacy to reduce malaria in sub-Saharan Africa where transmission rates are high, insecticide-treated nets are widely deployed, and mosquitoes are resistant to insecticides. Results will be submitted to the World Health Organization Vector Control Advisory Group for assessment of public health value towards an endorsement to recommend inclusion of spatial repellents in malaria control programs.

Trial registration: ClinicalTrials.gov NCT04766879 . Registered February 23, 2021.

Keywords: Clinical trial; Kenya; Malaria; Spatial repellent; Transfluthrin.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Location of 60 study clusters in Teso North and Teso South Districts, Busia County, western Kenya. Each cluster consists of a core area (discrete village) and a buffer zone extending 300–500 m outside the core area in which diversionary effects of the SR intervention on epidemiological and entomological endpoints will be measured

References

    1. WHO . World Malaria Report 2020. World Health Organization. 2020. p. 299.
    1. Were V, Buff AM, Desai M, Kariuki S, Samuels AM, Phillips-Howard P, et al. Trends in Malaria prevalence and health related socioeconomic inequality in Rural Western Kenya: results from repeated household malaria cross-sectional surveys from 2006 to 2013. BMJ Open. 2019;9(9):e033883. 10.1136/bmjopen-2019-033883.
    1. WHO . Global Vector Control Response 2017–2030. 2017.
    1. Ogoma SB, Moore SJ, Maia MF. A systematic review of mosquito coils and passive emanators: defining recommendations for spatial repellency testing methodologies. Parasit Vectors. 2012;5(1):287. doi: 10.1186/1756-3305-5-287.
    1. Achee NL, Bangs MJ, Farlow R, Killeen GF, Lindsay S, Logan JG, et al. Spatial repellents: from discovery and development to evidence-based validation. Malar J. 2012;11(1):164. 10.1186/1475-2875-11-164.
    1. Achee NL, Grieco JP. Current evidence, new insights, challenges and future outlooks to the use of spatial repellents for public health. In: Norris E, Coats J, editors. Advances in the Biorational Control of Medical and Veterinary Pests. Washington, DC: ACS Books; 2018. pp. 25–42.
    1. Norris E, Coats J. Current and future repellent technologies: the potential of spatial repellents and their place in mosquito-borne disease control. Int J Environ Res Public Health. 2017;14(2):124. doi: 10.3390/ijerph14020124.
    1. WHO . Guidelines for efficacy testing of spatial repellents. 2013.
    1. Grieco JP, Achee NL, Chareonviriyaphap T, Suwonkerd W, Chauhan K, Sardelis MR, et al. A new classification system for the actions of IRS chemicals traditionally used for malaria control. PLoS One. 2007;2(8):e716. 10.1371/journal.pone.0000716.
    1. Achee NL, Sardelis MR, Dusfour I, Chauhan KR, Grieco JP. Characterization of spatial repellent, contact irritant, and toxicant chemical actions of standard vector control compounds. J Am Mosq Control Assoc. 2009;25(2):156–167. doi: 10.2987/08-5831.1.
    1. Ogoma SB, Ngonyani H, Simfukwe ET, Mseka A, Moore J, Maia MF, et al. The mode of action of spatial repellents and their impact on vectorial capacity of Anopheles gambiae sensu stricto. PLoS ONE. 2014;9(12):e110433. 10.1371/journal.pone.0110433.
    1. Choi DB, Grieco JP, Apperson CS, Schal C, Ponnusamy L, Wesson DM, et al. Effect of spatial repellent exposure on dengue vector attraction to oviposition sites. PLoS Negl Trop Dis. 2016;10(7):e0004850. 10.1371/journal.pntd.0004850.
    1. Wagman JM, Grieco JP, Bautista K, Polanco J, Briceño I, King R, et al. The field evaluation of a push-pull system to control malaria vectors in Northern Belize, Central America. Malar J. 2015;14(1):184. 10.1186/s12936-015-0692-5.
    1. Bibbs CS, Hahn DA, Kaufman PE, Xue R. Sublethal effects of a vapour-active Pyrethroid, Transfluthrin, on Aedes aegypti and Ae. albopictus (Diptera: Culicidae) Fecundity and Oviposition Behaviour. Parasit Vectors. 2018;11(1):486. doi: 10.1186/s13071-018-3065-4.
    1. Horstmann S, Sonneck R. Contact bioassays with phenoxybenzyl and tetrafluorobenzyl pyrethroids against target-site and metabolic resistant mosquitoes. PloS one. 2016;11(3):e0149738. doi: 10.1371/journal.pone.0149738.
    1. U.S EPA Office of Pesticide Programs . Conventional new chemical registration decisions - completed FY 2018. United States Environmental Protection Agency. 2018.
    1. Debboun M, Frances SP, Strickman D. Insect repellents: principles, methods, and uses. Boca Raton: CRC Press; 2006.
    1. WHO . Guidelines for Malaria Vector Control. World Health Organization. 2019. pp. 1–171.
    1. Lucas JR, Shono Y, Iwasaki T, Ishiwatari T, Spero N, Benzon G. U.S. Laboratory and field trials of metofluthrin (SumiOne) emanators for reducing mosquito biting outdoors. J Am Mosq Control Assoc. 2007;23(1):47–54. doi: 10.2987/8756-971X(2007)23[47:ULAFTO];2.
    1. Kawada H, Temu EA, Minjas JN, Matsumoto O, Iwasaki T, Takagi M. Field evaluation of spatial repellency of metofluthrin-impregnated plastic strips against Anopheles gambiae complex in Bagamoyo, Coastal Tanzania. J Am Mosq Control Assoc. 2008;24(3):404–409. doi: 10.2987/5743.1.
    1. Devine GJ, Vazquez-Prokopec GM, Bibiano-Marín W, Pavia-Ruz N, Che-Mendoza A, Medina-Barreiro A, et al. The entomological impact of passive metofluthrin emanators against indoor Aedes aegypti: A Randomized Field Trial. PLoS Negl Trop Dis. 2021;15(1):e0009036. 10.1371/journal.pntd.0009036.
    1. Lucas JR, Shono Y, Iwasaki T, Ishiwatari T, Spero N. Field efficacy of metofluthrin – a new mosquito repellent. Proceedings of the Fifth International Conference on Urban Pests Chow-Yang Lee and William H. Robinson (editors). Malaysia: Perniagaan Ph’ng @ P&Y Design Network; 2005. p. 301–7.
    1. Kawada H, Maekawa Y, Tsuda Y, Takagi M. Laboratory and field evaluation of spatial repellency with metofluthrin-impregnated paper strip against mosquitoes in Lombok Island, Indonesia. J Am Mosq Control Assoc. 2004;20(3):292–298.
    1. Kawada H, Maekawa Y, Takagi M. Field trial on the spatial repellency of metofluthrin-impregnated plastic strips for mosquitoes in shelters without walls (Beruga) in Lombok, Indonesia. J Vector Ecol. 2005;30(2):181–185.
    1. Kawada H, Maekawa Y, Takagi M. Field trial on the spatial repellency of metofluthrin-impregnated resin strip against mosquitoes in shelters without walls (Beruga) in Lombok, Indonesia. Med Entomol Zool. 2005;56(Supplement):63. doi: 10.7601/mez.56.63_3.
    1. Syafruddin D, Asih PBS, Rozi IE, Permana DH, Nur Hidayati AP, Syahrani L, et al. Efficacy of a spatial repellent for control of malaria in Indonesia: a cluster-randomized controlled trial. Am J Trop Med Hyg. 2020;103(1):344–58. 10.4269/ajtmh.19-0554.
    1. Hill N, Zhou HN, Wang P, Guo X, Carneiro I, Moore SJ. A household randomized, controlled trial of the efficacy of 0.03% transfluthrin coils alone and in combination with long-lasting insecticidal nets on the incidence of Plasmodium falciparum and Plasmodium vivax Malaria in Western Yunnan Province, China. Malar J. 2014;13(1):208. doi: 10.1186/1475-2875-13-208.
    1. Morrison AC, Reiner RC, Elson WH, Astete H, Guevara C, del Aguila C, Bazan I, Siles C, Barrera P, Kawiecki AB, Barker CM, et al. Efficacy of a spatial repellent for control of Aedes-borne virus transmission: a cluster randomized trial in Iquitos, Peru. medRxiv. 2021. 10.1101/2021.03.03.21252148.
    1. Syafruddin D, Bangs MJ, Sidik D, Elyazar I, Asih PBS, Chan K, et al. Impact of a spatial repellent on malaria incidence in two villages in Sumba, Indonesia. Am J Trop Med Hyg. 2014;91(6):1079–1087. doi: 10.4269/ajtmh.13-0735.
    1. Hawley WA, Phillips-Howard PA, ter Kuile FO, Terlouw DJ, Vulule JM, Ombok M, et al. Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in Western Kenya. Am J Trop Med Hyg. 2003;68(4 Suppl):121–127. doi: 10.4269/ajtmh.2003.68.121.
    1. Ochomo E, Bayoh NM, Kamau L, Atieli F, Vulule J, Ouma C, et al. Pyrethroid susceptibility of malaria vectors in four districts of Western Kenya. Parasit Vectors. 2014;7(1):310. 10.1186/1756-3305-7-310.
    1. National Malaria Control Programme (NMCP). Kenya National Bureau of Statistics (KNBS) and ICF International. Kenya Malaria Indicator Survey 2015. Nairobi, Kenya, Rockville: NMCP, KNBS, and ICF International. 2016.
    1. Ochomo E, Chahilu M, Cook J, Kinyari T, Bayoh NM, West P, et al. Insecticide-treated nets and protection against insecticide-resistant malaria vectors in Western Kenya. Emerg Infect Dis. 2017;23(5):758–64. 10.3201/eid2305.161315.
    1. World Health Organization. How to design vector control efficacy trials: guidance on phase III vector control field trial design provided by the Vector Control Advisory Group. World Health Organization; 2017. .
    1. Millum J, Grady C. The ethics of placebo-controlled trials: methodological justifications. Contemp Clin Trials. 2013;36(2):514. doi: 10.1016/j.cct.2013.09.003.
    1. Lang S, Brezger A. Bayesian P-Splines. J Comput Graph Stat. 2004;13(1):183–212. doi: 10.1198/1061860043010.
    1. Yin G, Ibrahim JG. A class of Bayesian shared gamma frailty models with multivariate failure time data. Biometrics. 2005;61(1):208–216. doi: 10.1111/j.0006-341X.2005.030826.x.
    1. Law CG, Brookmeyer R. Effects of mid-point imputation on the analysis of doubly censored data. Stat Med. 1992;11(12):1569–1578. doi: 10.1002/sim.4780111204.
    1. Carlin BP, Hodges JS. Hierarchical proportional hazards regression models for highly stratified data. Biometrics. 1999;55(4):1162–1170. doi: 10.1111/j.0006-341X.1999.01162.x.
    1. Pan W. A multiple imputation approach to Cox regression with interval-censored data. Biometrics. 2000;56(1):199–203. doi: 10.1111/j.0006-341X.2000.00199.x.
    1. Henschel V, Engel J, Hölzel D, Mansmann U. A semiparametric Bayesian proportional hazards model for interval censored data with frailty effects. BMC Med Res Methodol. 2009;9(1):9. doi: 10.1186/1471-2288-9-9.
    1. Bretz F, Koenig F, Brannath W, Glimm E, Posch M. Adaptive designs for confirmatory clinical trials. Stat Med. 2009;28(8):1181–1217. doi: 10.1002/sim.3538.
    1. Schüler S, Kieser M, Rauch G. Choice of futility boundaries for group sequential designs with two endpoints. BMC Med Res Methodol. 2017;17(1):119. doi: 10.1186/s12874-017-0387-4.
    1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289–300.
    1. Achee NL, Grieco JP. Is it time to formally recognize spatial repellency for disease prevention? Outlooks Pest Manage. 2012;23(6):283–286. doi: 10.1564/23dec13.
    1. World Health Organization. Seventh meeting of the vector control advisory group, Geneva, Switzerland, 24–26 October 2017. World Health Organization. 2017.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera